UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003029 |
|---|---|
| Receipt number | R000003673 |
| Scientific Title | Phase II clinical trial of personalized peptide vaccination for liver cancer patients |
| Date of disclosure of the study information | 2010/01/13 |
| Last modified on | 2019/12/06 14:43:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/01/13 19:04:44 | ||
| 2 | Update | 2010/07/16 14:32:29 | Organization1 Tel1 Email1 |
|
| 3 | Update | 2014/07/10 15:42:15 | Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2014/12/12 11:42:55 | Key secondary outcomes |
|
| 5 | Update | 2014/12/12 11:44:56 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
| 6 | Update | 2019/01/07 10:55:03 | Recruitment status |
|
| 7 | Update | 2019/12/06 14:43:03 | Recruitment status Date of IRB Last follow-up date |
